Browsing by Author "Lockwood, C.J. (7102516684)"
Now showing 1 - 3 of 3
- Results Per Page
 - Sort Options
 
- Some of the metrics are blocked by yourconsent settings
Publication Fetal and maternal apolipoprotein A-I and B levels during the second half of pregnancy(1998) ;Radunovic, N. (7003538030) ;Lockwood, C.J. (7102516684) ;Kuczynski, E. (7003870928) ;Alvarez, M. (57208770409) ;Dukanac, J. (6506093302) ;Bozanovic, T. (57200447516)Dragojlovic, Z. (8895639400)Objective: To evaluate maternal and fetal apolipoprotein A-I and B (Lp A-I and Lp B) concentrations in uncomplicated pregnancies across the second half of pregnancy. Study design: Paired (n = 55) maternal and fetal umbilical venous samples were obtained at diagnostic cordocenteses from 20 to 36 weeks. Levels of Lp A-I and Lp B were measured by turbimetric assay. Results: Maternal Lp B (r = 0.30; p = 0.03) but not Lp A-I (r = -0.02, p = 0.5) levels displayed a significant correlation with gestational age. Moreover, the ratio of Lp B to Lp A-I significantly increased across gestation in maternal plasma (r = 0.30; p = 0.04). Fetal Lp A-I and Lp B values did not correlate with gestational age, or maternal Lp A-I or Lp B levels. Moreover, no significant correlation was found between the ratio of fetal plasma Lp B to Lp A-I and gestational age. The mean (± SD) maternal plasma Lp A-I concentration was significantly higher than the corresponding mean fetal Lp A-I level [1.55 (0.48) versus 0.78 (0.5); p < 0.001]. Similarly, the mean maternal Lp B level was significantly higher than the corresponding fetal value [1.28 (0.33) versus 0.46 (0.30); p < 0.001]. Conclusion: Fetal Lp A-I and Lp B levels were significantly lower than maternal levels and did not correlate with gestational age. - Some of the metrics are blocked by yourconsent settings
Publication Is Fetal Blood Sampling Associated with Increased Beta-Endorphin Release into the Fetal Circulation?(1993) ;Radunovic, N. (7003538030) ;Lockwood, C.J. (7102516684) ;Ghidini, A. (57192855823) ;Alvarez, M. (57208770409)Berkowitz, R.L. (35405190700)This study was conducted to determine whether fetal blood sampling during the second trimester is associated with changes in circulating fetal beta-endorphin (BE) concentrations. We measured BE concentrations in 68 paired fetal and maternal blood samples obtained between 18 and 28 weeks' gestation. Patients were divided into a control group (n = 50), if the fetal blood samples were obtained by a single umbilical cord puncture, or multiple insertion group (n = 18), if multiple cord punctures were required to obtain a sample. The mean (± SE) fetal BE value for the multiple insertion group was significantly higher than BE levels from the control group (771.2 ± 79.2 pg/ml versus 107.1 ±11.7 pg/ml; p<0.001]. This elevation did not appear to be related to acidosis, since no differences in fetal umbilical pH were observed between the two groups. Fetal BE levels from the control but not from the multiple insertion group significantly correlated with maternal values (Spearman rank r = 0.59; p <0.001 vs r = -0.08; p <0.5). In neither group did fetal BE levels correlate with gestational age. These findings indicate that multiple cord punctures at the time of fetal blood sampling are associated with significant increases in BE release. Furthermore, although a maternal or placental contribution to steady state circulating fetal BE cannot be excluded, it would seem that the fetus itself is the primary source of elevated circulating BE levels following multiple cord punctures. © 1993, by Thieme Medical Publishers, Inc. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication The stress hormone response to intrauterine transfusion Rh alloimmunized fetuses(1999) ;Radunovic, N. (7003538030) ;Nastic, D. (6602473098) ;Kuczynski, E. (7003870928)Lockwood, C.J. (7102516684)Objective To evaluate the effect of Rh alloimmunization and intrauterine transfusion on fetal stress hormone levels. Method Umbilical venous samples were obtained immediately prior to transfusion in 51 anemic fetuses and in a control group of 30 non-anemic fetuses. In 16 of the anemic fetuses a repeat sample was obtained post-transfusion. Samples were assessed for hematocrit, pH and levels of β-endorphin, cortisol and adrenocorticotropin. Results The mean initial hematocrit was significantly lower, while the median concentrations of β-endorphin and cortisol were higher in anemic compared with non-anemic fetuses at initial sampling. In contrast, fetal adrenocorticotropin levels did not differ between the groups. Among anemic fetuses, both serum β-endorphin and cortisol levels displayed a strong negative correlation with fetal hematocrit (r =- 0.46, p = 0.006 and r = - 0.54, p < 0.001, respectively). Among anemic fetuses sampled before and after transfusion, levels of β-endorphin were significantly lower, while cortisol levels were significantly higher post-transfusion. Maternal cortisol levels also increased post-transfusion. Conclusion Fetal anemia is associated with increased β-endorphin and cortisol levels. While intrauterine transfusion is associated with a decline in β-endorphin concentrations, fetal cortisol levels increase following transfusion, potentially reflecting transplacental passage of post-transfusion increases in maternal cortisol. 
